ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,567.11
      0.23%
      US Tech 100
      18,944.40
      -0.30%
      Dow Jones
      40,809.48
      0.37%
      Brent Oil
      78.535
      -0.38%
      Bitcoin
      58,350.81
      -0.41%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. 180 Life Sciences Corporation (ATNF)

      7. 180 Life Sciences Corporation (ATNF) Financials

      180 Life Sciences Corporation

      180 Life Sciences Corporation (ATNF)

      NASDAQ
      1.86
      0.06
      ( 3.33% )
      Updated: 10:10:13
      Delayed by 15 minutes

      180 Life Sciences Corporation Financial Summary

      The current ATNF market cap is 1.75M. The company's latest EPS is USD -21.1716 and P/E is -0.09.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -4.8M-3.68M-12.6M-1.45M-2.09M
      Net Income -4.76M-3.68M-10.27M-1.23M-1.07M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -1.21M-5.65M-15.64M-51.45M-22.54M
      Net Income -91k-10.88M-20.32M-38.73M-19.94M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 14.92M13.67M4.96M5.26M3.44M
      Total Liabilities 7.78M6.95M5.11M5.39M4.4M
      Total Equity 7.14M6.72M-149k-128k-954k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 12.5M55.53M62.71M19.65M5.26M
      Total Liabilities 7.16M25.25M23.39M8.31M5.39M
      Total Equity 5M30.29M39.32M11.34M-128k

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -3.87M-6.99M-8.76M-10.92M-1.03M
      Investing N/A N/A N/A N/A N/A
      Financing -470k1.99M4.44M5.91M-265k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -1.45M-3.87M-19.37M-12.13M-10.92M
      Investing 108.24M14.49M N/A N/A N/A
      Financing -106.51M-8.73M25.41M10.87M5.91M

      Stats and Ratios

      Market Cap 1.75M
      Price to Earnings Ratio -0.09
      Price to Sales Ratio 0
      Price to Cash Ratio 0.89
      Price to Book Ratio -13.68
      Dividend Yield -

      Share Statistics

      Shares Outstanding 941.59k
      Average Volume (1 week) 13.64k
      Average Volume (1 Month) 50.1k
      52 Week Change -85.14%
      52 Week High 15.7168
      52 Week Low 1.31
      Spread (Intraday) 0.16 (8.12%)

      Company Info

      Company Name 180 Life Sciences Corporation
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.180lifesciences.com
      Industry pharmaceutical preparations (2834)